Palbociclib and Fulvestrant in Breast Cancer. Reply

Nicholas C. Turner, Xin Huang, Massimo Cristofanilli

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalThe New England journal of medicine
Volume380
Issue number8
DOIs
StatePublished - Feb 21 2019

Fingerprint

Piperazines
Pyridines
Breast Neoplasms
palbociclib
fulvestrant

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{24c3afcbbd4e40c9ab2bcc7e7d1bb570,
title = "Palbociclib and Fulvestrant in Breast Cancer. Reply",
author = "Turner, {Nicholas C.} and Xin Huang and Massimo Cristofanilli",
year = "2019",
month = "2",
day = "21",
doi = "10.1056/NEJMc1816595",
language = "English (US)",
volume = "380",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "8",

}

Palbociclib and Fulvestrant in Breast Cancer. Reply. / Turner, Nicholas C.; Huang, Xin; Cristofanilli, Massimo.

In: The New England journal of medicine, Vol. 380, No. 8, 21.02.2019.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Palbociclib and Fulvestrant in Breast Cancer. Reply

AU - Turner, Nicholas C.

AU - Huang, Xin

AU - Cristofanilli, Massimo

PY - 2019/2/21

Y1 - 2019/2/21

UR - http://www.scopus.com/inward/record.url?scp=85062050465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062050465&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1816595

DO - 10.1056/NEJMc1816595

M3 - Letter

VL - 380

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 8

ER -